|
GALNT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.96459999957899E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.93679999991059E-07 |
| Normal-vs-Stage2 |
2.736600E-03 |
| Normal-vs-Stage3 |
1.66278999998992E-05 |
| Normal-vs-Stage4 |
6.46329999999251E-05 |
| Stage1-vs-Stage2 |
9.596000E-01 |
| Stage1-vs-Stage3 |
4.037800E-01 |
| Stage1-vs-Stage4 |
4.634800E-01 |
| Stage2-vs-Stage3 |
5.667400E-01 |
| Stage2-vs-Stage4 |
5.824800E-01 |
| Stage3-vs-Stage4 |
9.969200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.00820000032465E-07 |
| Normal-vs-AfricanAmerican |
1.489520E-02 |
| Normal-vs-Asian |
1.575010E-01 |
| Caucasian-vs-AfricanAmerican |
3.697800E-02 |
| Caucasian-vs-Asian |
5.619200E-01 |
| AfricanAmerican-vs-Asian |
3.529600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.41240000028908E-07 |
| Normal-vs-Female |
2.32269999999035E-05 |
| Male-vs-Female |
2.445800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.637700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.51619999999575E-06 |
| Normal-vs-Age(61-80Yrs) |
4.47859999996858E-06 |
| Normal-vs-Age(81-100Yrs) |
1.346630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.416800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.404000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.180200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.796000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.452240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.866630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.422120E-03 |
| Normal-vs-Grade 2 |
1.49179999997529E-06 |
| Normal-vs-Grade 3 |
2.0554000000006E-05 |
| Normal-vs-Grade 4 |
4.1979999999997E-05 |
| Grade 1-vs-Grade 2 |
5.127200E-01 |
| Grade 1-vs-Grade 3 |
2.159400E-01 |
| Grade 1-vs-Grade 4 |
8.444400E-01 |
| Grade 2-vs-Grade 3 |
1.992780E-01 |
| Grade 2-vs-Grade 4 |
4.817600E-01 |
| Grade 3-vs-Grade 4 |
1.473810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.2841999997888E-07 |
| Normal-vs-ccB subtype |
9.76439999966772E-08 |
| ccA subtype-vs-ccB subtype |
1.097780E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.47420000002386E-07 |
| Normal-vs-N1 |
4.199200E-03 |
| N0-vs-N1 |
6.973800E-01 |
|
|
